Evidence map›Paper›PMID 37932455›Full record

ArticleNature immunology2023

A discrete 'early-responder' stromal-cell subtype orchestrates immunocyte recruitment to injured tissue.

Omar K Yaghi, Bola S Hanna, P Kent Langston, Daniel A Michelson, Teshika Jayewickreme, Miguel Marin-Rodero, Christophe Benoist, Diane Mathis

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. [Core targets and immune regulatory mechanisms ofNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. The immunology of sickness metabolism.Cellular & molecular immunology · 2024
    Review
  16. Review
  17. Article
  18. Muscle stem cells as immunomodulator during regeneration.Current topics in developmental biology · 2024
    Review
  19. Comparative Analysis of Inflammatory Response in Surgical Wound Drainage Fluid in Scoliosis Surgery: A Study of Neuromuscular vs. Idiopathic Patients.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Omar K Yaghi *Department of Immunology, Harvard Medical School, Boston, MA, USA.
Bola S Hanna *Department of Immunology, Harvard Medical School, Boston, MA, USA.
P Kent LangstonDepartment of Immunology, Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-6655-1911
Daniel A MichelsonDepartment of Immunology, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-9434-5207
Teshika JayewickremeDepartment of Immunology, Harvard Medical School, Boston, MA, USA.
Miguel Marin-RoderoDepartment of Immunology, Harvard Medical School, Boston, MA, USA.
Christophe BenoistDepartment of Immunology, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-1172-6555
Diane MathisDepartment of Immunology, Harvard Medical School, Boston, MA, USA. dm@hms.harvard.edu.ORCID 0000-0002-6110-4626
Brigham and Women's Hospital · US

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Medical Scientist Training ProgramT32GM144273 · NIGMS · HARVARD MEDICAL SCHOOL · PI David Shumway Jones, Jacqueline A. Lees · 2022 to 2026
$14.7M
Muscle Tregs in health and diseaseR01AR070334 · NIAMS · HARVARD MEDICAL SCHOOL · PI MATHIS, DIANE J · 2016 to 2025
$3.7M
Muscle regulatory T cells in exercise and agingF32AG072874 · NIA · HARVARD MEDICAL SCHOOL · PI LANGSTON, PAUL KENT · 2021 to 2023
$210k
NIAMS NIH HHS R01 AR070334NIA NIH HHS F32 AG072874NIGMS NIH HHS T32 GM007753NIGMS NIH HHS T32 GM144273
6 · The paper itself

Abstract

Following acute injury, stromal cells promote tissue regeneration by a diversity of mechanisms. Time-resolved single-cell RNA sequencing of muscle mesenchymal stromal cells (MmSCs) responding to acute injury identified an 'early-responder' subtype that spiked on day 1 and expressed a notable array of transcripts encoding immunomodulators. IL-1β, TNF-α and oncostatin M each strongly and rapidly induced MmSCs transcribing this immunomodulatory program. Macrophages amplified the program but were not strictly required for its induction. Transfer of the inflammatory MmSC subtype, tagged with a unique surface marker, into healthy hindlimb muscle induced inflammation primarily driven by neutrophils and macrophages. Among the abundant inflammatory transcripts produced by this subtype, Cxcl5 was stroma-specific and highly upregulated with injury. Depletion of this chemokine early after injury revealed a substantial impact on recruitment of neutrophils, a prolongation of inflammation to later times and an effect on tissue regeneration. Mesenchymal stromal cell subtypes expressing a comparable inflammatory program were found in a mouse model of muscular dystrophy and in several other tissues and pathologies in both mice and humans. These 'early-responder' mesenchymal stromal cells, already in place, permit rapid and coordinated mobilization and amplification of critical cell collaborators in response to injury.

Indexed as

InflammationMesenchymal Stem CellsAnimalsHumansMacrophagesMiceNeutrophilsWound Healing

Identifiers

PMID37932455
PMCPMC10792729
OpenAlexW4388425210

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.